Bio-Path Holdings, Inc. short interest in 2023
In 2023, Bio-Path Holdings, Inc.'s disclosed short interest ran from 0.17% of shares outstanding on 13 Jan 2023 to 3.04% on 29 Dec 2023, a change of +2.87 percentage points. The year's high was 5.63% on 15 Nov 2023 and its low 0.17% on 13 Jan 2023, averaging 1.99% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.56 days on 30 Nov 2023. Full history: Bio-Path Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2023 in figures
- Start of year
- 0.17% (13 Jan 2023)
- End of year
- 3.04% (29 Dec 2023)
- Change
- +2.87 pp
- High
- 5.63% (15 Nov 2023)
- Low
- 0.17% (13 Jan 2023)
- Average
- 1.99%
- Highest days to cover
- 5.56 (30 Nov 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.17% | 1.00 | |
| 31 Jan 2023 | 0.37% | 1.00 | |
| 15 Feb 2023 | 0.56% | 1.04 | |
| 28 Feb 2023 | 0.89% | 1.55 | |
| 15 Mar 2023 | 0.81% | 2.32 | |
| 31 Mar 2023 | 0.95% | 2.34 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 1.05% | 4.03 | |
| 28 Apr 2023 | 0.88% | 2.53 | |
| 15 May 2023 | 0.94% | 3.87 | 10-Q filed, results (8-K) |
| 31 May 2023 | 1.01% | 2.90 | |
| 15 Jun 2023 | 1.16% | 3.88 | |
| 30 Jun 2023 | 2.46% | 2.67 | |
| 14 Jul 2023 | 3.57% | 5.55 | |
| 31 Jul 2023 | 5.14% | 2.52 | |
| 15 Aug 2023 | 1.90% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 1.54% | 1.37 | |
| 15 Sep 2023 | 1.89% | 4.21 | |
| 29 Sep 2023 | 1.49% | 2.41 | |
| 13 Oct 2023 | 2.49% | 1.00 | |
| 15 Nov 2023 | 5.63% | 3.80 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 4.29% | 5.56 | |
| 15 Dec 2023 | 3.49% | 4.52 | |
| 29 Dec 2023 | 3.04% | 3.62 |
See also: Bio-Path Holdings, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.